[ ⁸⁹ Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.

Autor: Shuch B; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: bshuch@mednet.ucla.edu., Pantuck AJ; Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA., Bernhard JC; Department of Urology, Centre Hospitalier Universitaire de Bordeaux-Groupe Hospitalier Pellegrin, Bordeaux, France., Morris MA; United Theranostics, Glen Burnie, Baltimore, MD, USA., Master V; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., van Praet C; Department of Urology, Ghent University Hospital, Ghent, Belgium., Bailly C; Department of Nuclear Medicine, Nantes University Hospital, Nantes, France., Önal B; Department of Urology, Istanbul University-Cerrahpasa, Istanbul, Turkey., Aksoy T; Department of Nuclear Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey., Merkx R; Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands., Schuster DM; Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA., Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Pandit-Taskar N; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA., Fan AC; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Allman P; Premier Research, Morrisville, NC, USA., Schmidt K; ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft, Dresden, Germany., Tauchmanova L; Telix Pharmaceuticals, Melbourne, VIC, Australia., Wheatcroft M; Telix Pharmaceuticals, Melbourne, VIC, Australia., Behrenbruch C; Telix Pharmaceuticals, Melbourne, VIC, Australia., Hayward CRW; Telix Pharmaceuticals, Melbourne, VIC, Australia., Mulders P; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Oct; Vol. 25 (10), pp. 1277-1287. Date of Electronic Publication: 2024 Sep 10.

A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors.

Autor: Leerink JM; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Baat EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Merkx R; Radboud University Medical Center, Department of Medical Imaging, Nijmegen, the Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Beatrix Children's Hospital, Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands., Versluys AB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Willem Alexander Children's Hospital/Leiden University Medical Center, Leiden, the Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Carl von Ossietzky University of Oldenburg, Oldenburg, Germany., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Neggers S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, the Netherlands., Kapusta L; Radboud University Medical Center, Department of Pediatric Cardiology, Amalia Children's Hospital, Nijmegen, the Netherlands.; Pediatrics, Pediatric Cardiology Unit, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Loonen J; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., Pinto YM; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, the Netherlands.; Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Amsterdam, the Netherlands., Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kok WEM; Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2024 Apr 16; Vol. 6 (2), pp. 236-247. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).

Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors: A DCCSS LATER Study.

Autor: Merkx R; Medical Imaging/Radiology, Medical UltraSound Imaging Centre, Radboud Institute for Health Sciences, Radboud university medical center, the Netherlands., Leerink JM; Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Feijen ELAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Baat EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bellersen L; Cardiology, Radboud university medical center, Nijmegen, the Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Dulmen-den Broeder E; Pediatric Oncology, Amsterdam UMC, VU University, Amsterdam, the Netherlands., van der Heiden-van der Loo M; Trial- and Data Center, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, the Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands., Kok JL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Louwerens M; Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands., Maas AHEM; Cardiology, Radboud university medical center, Nijmegen, the Netherlands., Neggers SJCMM; Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Childhood Cancer Epidemiology/German Childhood Cancer Registry, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Teske AJ; Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, the Netherlands., Weijers G; Medical Imaging/Radiology, Medical UltraSound Imaging Centre, Radboud Institute for Health Sciences, Radboud university medical center, the Netherlands., de Korte CL; Medical Imaging/Radiology, Medical UltraSound Imaging Centre, Radboud Institute for Health Sciences, Radboud university medical center, the Netherlands., Loonen J; Hematology, Radboud university medical center, Nijmegen, the Netherlands., Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.; Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Kok WEM; Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Kapusta L; Pediatrics, Pediatric Cardiology Unit, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Pediatric Cardiology, Amalia Children's Hospital, Radboud university medical center, Nijmegen, the Netherlands.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2023 Aug 15; Vol. 5 (4), pp. 472-485. Date of Electronic Publication: 2023 Aug 15 (Print Publication: 2023).

Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Autor: Ehrhardt MJ; Department of Oncology and Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: matthew.ehrhardt@stjude.org., Leerink JM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Mulder RL; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Mavinkurve-Groothuis A; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Kok W; Department of Clinical and Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Nohria A; Department of Internal Medicine, Division of Cardiology, Brigham and Women's Hospital, Boston, MA, USA., Nathan PC; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada., Merkx R; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands., de Baat E; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Asogwa OA; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Skinner R; Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Newcastle upon Tyne, UK; Newcastle University Centre for Cancer, Newcastle upon Tyne, UK., Wallace H; Department of haematology and oncology, Royal Hospital for Sick Children and Young People, Edinburgh, UK; University of Edinburgh, Edinburgh, UK., Lieke Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., de Ville de Goyet M; Pediatric Hematology & Oncology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium; Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium., Prasad M; Division of Paediatric Oncology, Tata Memorial Hospital, Mumbai, India; Homi Bhabha National Institute, Mumbai, India., Bárdi E; Hematoonokological and Immunological Outpatient Department, St Anna Children's Hospital, Vienna, Austria; Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria., Pavasovic V; Department Paediatric Haemato-Oncology, Great Ormond Street Hospital for Children NHS Trust, London, UK., van der Pal H; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Fresneau B; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Demoor-Goldschmidt C; Radiation Epidemiology Team, INSERM U1018, Paris-Sud XI University, Centre for Research in Epidemiology and Population Health, Cancer & Radiations Group, Gustave Roussy, Villejuif, France; Department of Pediatric Hematology and Oncology, CHU Angers, Angers, France; Department of Radiotherapy and Supportive care department, François Baclesse Center, Caen, France., Hennewig U; Department of Pediatric Hematology and Oncology, University Hospital of Giessen and Marburg, Giessen, Germany., Steinberger J; Department of Pediatric Cardiology, University of Minnesota School of Medicine, Minneapolis, MN, USA., Plummer C; Department of Cardiology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Chen MH; Department of Cardiology and Pediatrics, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA., Teske AJ; Department of Cardiology, Division of Heart and Lung, University Medical Center Utrecht, Utrecht, Netherlands., Haddy N; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Radiation Epidemiology Team, INSERM U1018, Paris-Sud XI University, Centre for Research in Epidemiology and Population Health, Cancer & Radiations Group, Gustave Roussy, Villejuif, France., van Dalen EC; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Constine LS; Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA., Chow EJ; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA; Division of Clinical Research and Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Levitt G; Department of Oncology, Great Ormond Street Hospital for Children NHS Trust, London, UK., Hudson MM; Department of Oncology and Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN, USA., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam UMC, Amsterdam, Netherlands., Armenian SH; Department of Pediatrics and Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Mar; Vol. 24 (3), pp. e108-e120. Date of Electronic Publication: 2023 Feb 14.

Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review

Autor: Leerink, J.M., Baat, E.C. de, Feijen, E.A.M., Bellersen, L., Dalen, E.C. van, Grotenhuis, H.B., Kapusta, L., Kok, W.E., Loonen, J.J., Pal, H.J. van der, Pluijm, S.M.F., Teske, A.J., Mavinkurve-Groothuis, A.M.C., Merkx, R., Kremer, L.C.

Publikováno v: JACC. CardioOncology, 2, 3, pp. 363-378
JACC. CardioOncology, 2, 363-378

Contains fulltext : 225154.pdf (Publisher’s version ) (Open Access) Cardiac diseases in the growing population of childhood cancer survivors are of major concern. Cardiotoxicity as a consequence of anthracyclines and chest radiotherapy continues to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aa143606124ca7215a428df2e6b027d0
https://hdl.handle.net/2066/225154